Apolipoprotein E (APOE) is the most abundant apolipoprotein in the brain, where it is primarily expressed and secreted by astrocytes and microglia. APOE seems to exert immunomodulatory effects in an isoform-dependent way, and a new study indicates that the APOE isoform dictates the glycosylation state and secretion of this apolipoprotein.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The multifaceted roles of apolipoprotein E4 in Alzheimer’s disease pathology and potential therapeutic strategies
Cell Death Discovery Open Access 08 July 2025
-
iPSC-derived blood-brain barrier modeling reveals APOE isoform-dependent interactions with amyloid beta
Fluids and Barriers of the CNS Open Access 11 October 2024
-
Solving neurodegeneration: common mechanisms and strategies for new treatments
Molecular Neurodegeneration Open Access 21 March 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Yamazaki, Y., Zhao, N., Caulfield, T. R., Liu, C. C. & Bu, G. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat. Rev. Neurol. 15, 501–518 (2019).
Kloske, C. M. & Wilcock, D. M. The important interface between apolipoprotein E and neuroinflammation in Alzheimer’s disease. Front. Immunol. 11, 754 (2020).
Lanfranco, M. F., Sepulveda, J., Kopetsky, G. & Rebeck, G. W. Expression and secretion of apoE isoforms in astrocytes and microglia during inflammation. Glia https://doi.org/10.1002/glia.23974 (2021).
Zhang, Y. et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci. 34, 11929–11947 (2014).
Lynch, J. R. et al. APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response. J. Biol. Chem. 278, 48529–48533 (2003).
Shi, Y. et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature 549, 523–527 (2017).
Julia, T. C. W. et al. Cholesterol and matrisome pathways dysregulated in human APOE ε4 glia. Preprint at bioRxiv https://doi.org/10.1101/713362 (2019).
Yin, C. et al. ApoE attenuates unresolvable inflammation by complex formation with activated C1q. Nat. Med. 25, 496–506 (2019).
Hong, S. et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 352, 712–716 (2016).
Trumble, B. C. et al. Apolipoprotein E4 is associated with improved cognitive function in Amazonian forager-horticulturalists with a high parasite burden. FASEB J. 31, 1508–1515 (2017).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Hasel, P., Liddelow, S.A. Isoform-dependent APOE secretion modulates neuroinflammation. Nat Rev Neurol 17, 265–266 (2021). https://doi.org/10.1038/s41582-021-00483-y
Published:
Issue date:
DOI: https://doi.org/10.1038/s41582-021-00483-y
This article is cited by
-
The multifaceted roles of apolipoprotein E4 in Alzheimer’s disease pathology and potential therapeutic strategies
Cell Death Discovery (2025)
-
Exploring the interconnection between PANoptosis and chronic inflammatory diseases: identifying key targets and therapeutic strategies for periodontitis and ulcerative colitis
Naunyn-Schmiedeberg's Archives of Pharmacology (2025)
-
iPSC-derived blood-brain barrier modeling reveals APOE isoform-dependent interactions with amyloid beta
Fluids and Barriers of the CNS (2024)
-
Solving neurodegeneration: common mechanisms and strategies for new treatments
Molecular Neurodegeneration (2022)
